CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Wanbury Ltd

Wanbury Ltd

BSE 524212 WANBURY INE107F01022
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

24 filings · 11 material · busiest 2026-08-11

What it files

Press Release6 General4 SAST3 Change in Management2 Board Outcome1 Results1 ESOP Allotment1 Board Meeting1

Filings

24 in the window

  1. 13 August 2026

    Press Release

    Press Release / Media Release

    Press Release regarding EDQM approval for new product Rivaroxaban API, USFDA DMF Clearances.

    Company Update / Press Release / Media Release View filing →

  2. 11 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Held On August 11, 2026

    Outcome of the Board Meeting held on August 11, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  3. 11 August 2026

    Results

    Financial Results For The First Quarter Ended 30Th June, 2026

    Financial Results for the first quarter ended 30th June, 2026

    Result / Financial Results View filing →

  4. 11 August 2026

    Change in Management

    Change in Management

    Outcome of the Board Meeting held on August 11, 2026

    Company Update / Change in Management View filing →

  5. 11 August 2026

    Press Release

    Press Release / Media Release

    Press Release on Un-audited Financial Results for the quarter ended 30th June, 2026

    Company Update / Press Release / Media Release View filing →

  6. 11 August 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    Outcome of the Board Meeting held on August 11, 2026

    Company Update / Allotment of ESOP / ESPS View filing →

  7. 3 August 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Wanbury Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Notice is hereby given pursuant to ....

    Board Meeting / Board Meeting View filing →

  8. 30 July 2026

    Press Release

    Press Release / Media Release

    Press Release - No DMF deficiency letter received from the office of USFDA for multiple ANDAs

    Company Update / Press Release / Media Release View filing →

  9. 22 July 2026

    General

    Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Company's Facility At Tanuku, West Godavari District, Andhra Pradesh

    Intimation of completion of inspection by the United States Food and Drug Administration (USFDA) at the Company's Facilty.

    Company Update / General View filing →

  10. 20 July 2026

    General

    Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Company's Facility At Tanuku, West Godavari District, Andhra Pradesh

    A Current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Company's facility at Tanuku, West Godavari District, ....

    Company Update / General View filing →

  11. 17 July 2026

    General

    Clarification On Price Movement

    We would like to inform you that the relevant information required to be disclosed under applicable laws has already been disclosed to the stock exhange from time to time in the recent ....

    Company Update / General View filing →

  12. 16 July 2026

    Clarification

    Clarification sought from Wanbury Ltd

    The Exchange has sought clarification from Wanbury Ltd on July 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....

    Company Update / Clarification

  13. 15 July 2026

    General

    Resolution Passed Through Circulation By The Board Of Directors Of The Company

    Resolution passed through circulation by the Board of Directors of the Company regarding early redemption in full of 12.5% secured, guaranteed, senior, taxable, non-cumulative, unrated, ....

    Company Update / General View filing →

  14. 13 July 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  15. 9 July 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  16. 9 July 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  17. 7 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  18. 1 July 2026

    Investor Presentation

    Investor Presentation

    Investor Presentation on Audited Financial Results (AFR) for the quarter and year ended 31st March, 2026 and is also available on the website of the Company at www.wanbury.com

    Company Update / Investor Presentation View filing →

  19. 26 June 2026

    Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Dated 26.06.2026

    Outcome of the Board Meeting dated 26.06.2026

    Others / Outcome without intimation View filing →

  20. 26 June 2026

    Change in Management

    Change in Management

    Outcome of the Board Meeting - Change in Management

    Company Update / Change in Management View filing →

  21. 25 June 2026

    Press Release

    Press Release / Media Release

    Press Release dated 25.06.2026 titled Intimation of pledge being released on equity shares held by the Promoter Group and reduction in rate of interest from 12.5% per annum to Sub 10% per annum.

    Company Update / Press Release / Media Release View filing →

  22. 25 June 2026

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  23. 10 June 2026

    Press Release

    Press Release / Media Release

    Press Release on Quality inspection by the Therapeutic Goods Administration (TGA) at Tanuku, Andhra Pradesh

    Company Update / Press Release / Media Release View filing →

  24. 9 June 2026

    Press Release

    Press Release / Media Release

    Press Release on Launch of New APIs.

    Company Update / Press Release / Media Release View filing →